According to researchers at Wake Forest School of Medicine, that is a fair possibility. In a small pilot study, the researchers identified several distinct gut microbiome signatures — the chemicals produced by bacteria — in study participants with mild cognitive impairment (MCI) but not in their counterparts with normal cognition, and found that these bacterial […]
Read More
Around the world, the number of people diagnosed with autism is rising. In the United States, the prevalence of the disorder has grown from 0.05% in 1966 to more than 2% today. In Quebec, the reported prevalence is close to 2% and according to a paper issued by the province’s public health department, the prevalence […]
Read More
Alzheimer’s disease, the most common cause of dementia among the elderly, is characterized by plaques and tangles in the brain, with most efforts at finding a cure focused on these abnormal structures. But a University of California, Riverside, research team has identified alternate chemistry that could account for the various pathologies associated with the disease. […]
Read More
When it comes to protecting the newborn brain, taking steps to mitigate risk before birth may be critical. Some newborns, such as those with intrauterine growth restriction (IUGR), are at heightened risk. Being able to intervene before birth to aid in protecting the newborn brain may prevent the often-devastating effects of brain injury. In ongoing […]
Read More
The Neurology Center, a medical group practice of top doctors devoted to excellence in care, located in Houston, Texas, working in conjunction with two leading neurology and anti-aging specialists, has made available the concluding six-month results of their randomized controlled investigation of intravenously administering NuPlasma® young blood plasma into eighteen Parkinson’s disease patients (8 NuPlasma […]
Read More
A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future. The model could be used to improve the selection of candidate drugs and participant cohorts for […]
Read More
A new paper that challenges widely held ideas about autism has attracted comments from more than 30 scholars across the disciplines of psychology, anthropology, education, and neuroscience. The authors maintain that many of the behaviors common to autism — including low eye contact, repetitive movements, and the verbatim repetition of words and phrases — are […]
Read MoreA new study by Montreal scientists published today in Nature demonstrates that a gut infection can lead to a pathology resembling Parkinson’s disease (PD) in a mouse model lacking a gene linked to the human disease. This discovery extends recent work by the same group suggesting that PD has a major immune component, providing new […]
Read More
Years before symptoms of Alzheimer’s disease appear, two kinds of damaging proteins silently collect in the brain: amyloid beta and tau. Clumps of amyloid accumulate first, but tau is particularly noxious. Wherever tangles of the tau protein appear, brain tissue dies, triggering the confusion and memory loss that are hallmarks of Alzheimer’s. Now, researchers at […]
Read More
They say the results advance the hope that supplementing with broccoli sprout extract, which contains high levels of the chemical cruciferous vegetables, may someday provide a way to lower the doses of traditional antipsychotic medicines needed to manage schizophrenia symptoms, thus reducing unwanted side effects of the medicines. “It’s possible that future studies could show […]
Read More